From the American Head and Neck Society
Vivian L. Zhu, MD; Dayton R. Rand, BSBA; Kiranya E. Arnold, MBBS; et al.
JAMA Otolaryngol Head Neck Surg. 2023;149(11):955-960. doi:10.1001/jamaoto.2023.1897
This cohort study assesses whether preoperative nodal core needle biopsy is associated with presence of extranodal extension in final pathology findings among patients with human papillomavirus (HPV)–associated oropharyngeal squamous cell carcinoma targeted for primary surgical resection.
From the American Head and Neck Society
Gabriel S. Dayan, MD; Houda Bahig, MD, PhD; Stephanie Johnson-Obaseki, MD, MPH; et al.
free access
JAMA Otolaryngol Head Neck Surg. 2023;149(11):961-969. doi:10.1001/jamaoto.2023.1936
This cohort study reports treatment delays for patients with oral cavity cancer in Canada and evaluates the outcome of treatment delays on overall survival.
-
Invited Commentary
Treatment Delays in Oral Cavity Cancer—Time, Time, Time, See What’s Become of Me
Evan M. Graboyes, MD, MPH; Sue S. Yom, MD, PhD, MAS
JAMA Otolaryngol Head Neck Surg
From the American Head and Neck Society
Rocco M. Ferrandino, MD, MSCR; Sida Chen, MD; Catharine Kappauf, MD; et al.
free access
JAMA Otolaryngol Head Neck Surg. 2023;149(11):971-977. doi:10.1001/jamaoto.2023.1937
This cohort study aims to establish the clinical efficacy of plasma tumor tissue–modified human papillomavirus DNA testing in the diagnosis and surveillance of human papillomavirus–associated oropharyngeal squamous cell carcinoma in a contemporary clinical setting.
-
Invited Commentary
Circulating Human Papillomavirus Tumor DNA—Ready for Prime Time?
Miriam N. Lango, MD
JAMA Otolaryngol Head Neck Surg
From the American Head and Neck Society
Dev R. Amin, MD; Ramez Philips, MD; Dylan G. Bertoni, MD, MS; et al.
free access
JAMA Otolaryngol Head Neck Surg. 2023;149(11):980-986. doi:10.1001/jamaoto.2023.1944
This national multicenter cohort study of patients with T1-T2 oropharyngeal squamous cell carcinoma compares the functional and survival outcomes of primary transoral robotic surgery vs primary radiation therapy and/or chemoradiation.
From the American Head and Neck Society
Hilary C. McCrary, MD, MPH; Molly Meeker, BS; Janice L. Farlow, MD, PhD; et al.
JAMA Otolaryngol Head Neck Surg. 2023;149(11):987-992. doi:10.1001/jamaoto.2023.2021
This cross-sectional study assesses demographic trends and academic productivity among American Head & Neck Society fellowship graduates.
From the American Head and Neck Society
Louise Davies, MD, MS; Benjamin F. Hankey, PhD; Zhuoqiao Wang, MS; et al.
open access
JAMA Otolaryngol Head Neck Surg. 2023;149(11):993-1000. doi:10.1001/jamaoto.2023.1975
This decision analytical model study of US adults with oral cancer uses health records linked with Medicare files to model an oral cancer survival calculator accounting for other health-related causes of death.
-
Invited Commentary
Novel Oral Cancer Survival Calculator—Do We Have a Crystal Ball?
Leila J. Mady, MD, PhD, MPH; Wayne M. Koch, MD; Carole Fakhry, MD, MPH
JAMA Otolaryngol Head Neck Surg
From the American Head and Neck Society
Katherine P. Wallerius, MD; Katherine Z. Xie, BS; Lauren Y. Lu, BS; et al.
JAMA Otolaryngol Head Neck Surg. 2023;149(11):1003-1010. doi:10.1001/jamaoto.2023.2981
This case series compares selective deep lobe parotidectomy vs total parotidectomy for patients with benign tumors in the deep lobe for postoperative complications and tumor control and recurrence.
From the American Head and Neck Society
Shannon S. Wu, MD; Neil Woody, MD; Jennifer Hesse, BS; et al.
JAMA Otolaryngol Head Neck Surg. 2023;149(11):1011-1020. doi:10.1001/jamaoto.2023.2982
This retrospective study of margin assessment methods after oral cavity squamous cell carcinoma resection compares tumor bed vs resection specimen sampling and the risk of recurrence.
From the American Head and Neck Society
Pratyusha Yalamanchi, MD, MBA; Nithin S. Peddireddy, MD, MBA; Brennan McMichael, BA; et al.
JAMA Otolaryngol Head Neck Surg. 2023;149(11):1021-1026. doi:10.1001/jamaoto.2023.3028
This cohort study investigates the association of team-based surgical approaches with intraoperative and postoperative outcomes for patients undergoing head and neck free flap reconstruction.
From the American Head and Neck Society
Friedrich Mrosk, MD; Christian Doll, MD, DMD; Julia Scheer, DMD; et al.
JAMA Otolaryngol Head Neck Surg. 2023;149(11):1027-1033. doi:10.1001/jamaoto.2023.3111
This cohort study evaluates survival and recurrence for patients with and without recommended adjuvant therapy after resection of advanced oral squamous cell carcinoma.
From the American Head and Neck Society
Helena Levyn, MD; Tejas Subramanian, BE; Alana Eagan, MPH; et al.
JAMA Otolaryngol Head Neck Surg. 2023;149(11):1034-1041. doi:10.1001/jamaoto.2023.3212
This cohort study examined the rate of carcinoma ex pleomorphic adenoma (CXPA) detection in untreated pleomorphic adenomas of the parotid gland and factors associated with development of CXPA.